Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 613 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
14 Jun 2022
CVP, Japan & Intercontinental
Sold, plan not stated
3,675
$322.48K
3.6%
13 Jun 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$605.41K
9.7%
1 Jun 2022
CVP, TAVR
Sold, plan not stated
7,242
$728.05K
3.5%
31 May 2022
CVP, TMTT
Sold, plan not stated
9,000
$907.49K
22.6%
26 May 2022
CVP, Surgical Structural Heart
Sold, plan not stated
1,000
$98.31K
4.8%
24 May 2022
CVP, TMTT
Sold, plan not stated
4,809
$459.36K
10.8%
10 May 2022
Chairman & CEO
Sold, plan not stated
32,550
$3.09M
17.1%
10 May 2022
CVP, TAVR
Sold, plan not stated
7,242
$696.18K
3.4%
9 May 2022
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
11,560
$1.14M
6.6%
9 May 2022
CVP,Strategy/Corp Development
Sold, plan not stated
6,725
$663.82K
9.5%
9 May 2022
CVP, Japan & Intercontinental
Sold, plan not stated
3,675
$362.76K
3.5%
4 May 2022
CVP, Critical Care
Sold, plan not stated
23,400
$2.45M
43.1%
29 Apr 2022
Chairman & CEO
Sold, plan not stated
32,550
$3.51M
26.2%
28 Apr 2022
Director
Sold, plan not stated
28,722
$3.10M
51.8%
11 Apr 2022
CVP, Critical Care
Sold, plan not stated
20,000
$2.44M
42.0%
8 Apr 2022
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
11,660
$1.44M
7.1%
8 Apr 2022
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.36M
16.3%
8 Apr 2022
CVP, Japan & Intercontinental
Sold, plan not stated
3,675
$452.28K
3.6%
5 Apr 2022
CVP, TAVR
Sold, plan not stated
7,242
$876.53K
3.5%
22 Mar 2022
Chairman & CEO
Sold, plan not stated
32,550
$3.66M
29.1%
14 Mar 2022
CVP, Critical Care
Sold, plan not stated
20,000
$2.09M
42.2%
11 Mar 2022
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
11,660
$1.24M
7.1%
11 Mar 2022
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.17M
16.4%
8 Mar 2022
CVP, TAVR
Sold, plan not stated
7,242
$772.18K
3.5%
8 Mar 2022
CVP, Japan & Intercontinental
Sold, plan not stated
3,675
$395.43K
3.6%
18 Feb 2022
CVP, Critical Care
Sold, plan not stated
20,000
$2.13M
42.2%
15 Feb 2022
Chairman & CEO
Sold, plan not stated
32,550
$3.58M
29.1%
11 Feb 2022
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.23M
16.4%
8 Feb 2022
Director
Sold, plan not stated
32,256
$3.57M
90.4%
8 Feb 2022
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$699.77K
6.1%
8 Feb 2022
CVP, TAVR
Sold, plan not stated
4,386
$480.48K
2.2%
28 Jan 2022
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.12M
16.1%
14 Jan 2022
CVP, Critical Care
Sold, plan not stated
10,000
$1.20M
26.7%
7 Jan 2022
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$775.72K
6.1%
6 Jan 2022
Chairman & CEO
Sold, plan not stated
32,550
$4.03M
14.8%
20 Dec 2021
Chairman & CEO
Sold, plan not stated
32,550
$3.88M
14.8%
17 Dec 2021
CVP, Critical Care
Sold, plan not stated
10,000
$1.21M
26.7%
10 Dec 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.34M
16.4%
10 Dec 2021
CVP, TAVR
Sold, plan not stated
7,830
$951.27K
3.8%
10 Dec 2021
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$771.52K
6.1%
29 Nov 2021
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
100
$11.06K
0.1%
24 Nov 2021
Director
Bought
1,500
$168.35K
2.4%
18 Nov 2021
CVP, Critical Care
Sold, plan not stated
10,000
$1.18M
26.7%
10 Nov 2021
CVP, TAVR
Sold, plan not stated
7,830
$937.96K
2.1%
9 Nov 2021
Chairman & CEO
Sold, plan not stated
32,550
$3.90M
14.8%
8 Nov 2021
CVP, Japan & Intercontinental
Sold, plan not stated
6,350
$758.19K
6.1%
5 Nov 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.29M
16.4%
18 Oct 2021
CVP, Critical Care
Sold, plan not stated
9,741
$1.08M
26.2%
11 Oct 2021
CVP, TAVR
Sold, plan not stated
7,830
$845.64K
2.1%
8 Oct 2021
CVP,Strategy/Corp Development
Sold, plan not stated
11,050
$1.22M
16.4%
Showing 201–250 of 613. ← Newer Page 5 of 13 Older →